Tim O. Lankisch

2.6k total citations
67 papers, 1.7k citations indexed

About

Tim O. Lankisch is a scholar working on Surgery, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tim O. Lankisch has authored 67 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Surgery, 27 papers in Hepatology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tim O. Lankisch's work include Liver Diseases and Immunity (22 papers), Gallbladder and Bile Duct Disorders (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Tim O. Lankisch is often cited by papers focused on Liver Diseases and Immunity (22 papers), Gallbladder and Bile Duct Disorders (15 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Tim O. Lankisch collaborates with scholars based in Germany, United States and Austria. Tim O. Lankisch's co-authors include Michael P. Manns, Christian P. Strassburg, Torsten Voigtländer, Ahmed Negm, Jochen Wedemeyer, Tobias J. Weismüller, Jochen Metzger, Ursula Ehmer, Andrea Schneider and Harald Mischak and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Tim O. Lankisch

64 papers receiving 1.7k citations

Peers

Tim O. Lankisch
G. Otto Germany
David N. Assis United States
J Klupp Germany
Joris Grond Netherlands
Alexander Miethke United States
G. Otto Germany
Tim O. Lankisch
Citations per year, relative to Tim O. Lankisch Tim O. Lankisch (= 1×) peers G. Otto

Countries citing papers authored by Tim O. Lankisch

Since Specialization
Citations

This map shows the geographic impact of Tim O. Lankisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim O. Lankisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim O. Lankisch more than expected).

Fields of papers citing papers by Tim O. Lankisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim O. Lankisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim O. Lankisch. The network helps show where Tim O. Lankisch may publish in the future.

Co-authorship network of co-authors of Tim O. Lankisch

This figure shows the co-authorship network connecting the top 25 collaborators of Tim O. Lankisch. A scholar is included among the top collaborators of Tim O. Lankisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim O. Lankisch. Tim O. Lankisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Voigtländer, Torsten, Jochen Metzger, Mark D. Jäger, et al.. (2017). A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin. United European Gastroenterology Journal. 5(5). 668–676. 26 indexed citations
2.
Jüngst, Christoph, Vanessa Stadlbauer, Matthias Reichert, et al.. (2017). NOD2 gene variants confer risk for secondary sclerosing cholangitis in critically ill patients. Scientific Reports. 7(1). 7026–7026. 7 indexed citations
3.
Marquardt, Nicole, Vivien Béziat, Sanna Nyström, et al.. (2015). Cutting Edge: Identification and Characterization of Human Intrahepatic CD49a+ NK Cells. The Journal of Immunology. 194(6). 2467–2471. 199 indexed citations
4.
Erichsen, Thomas, Ralf‐Peter Vonberg, Henrike Lenzen, et al.. (2015). Microbiological Analysis of Fluids in Postsurgical Gastroesophageal Intrathoracic Leaks Obtained by Endoscopy: A New Way to Optimize Antibiotic Therapy. Digestion. 91(3). 202–207. 3 indexed citations
5.
Voigtländer, Torsten & Tim O. Lankisch. (2015). Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics. Best Practice & Research Clinical Gastroenterology. 29(2). 267–275. 17 indexed citations
6.
Voigtländer, Torsten, Ralf‐Peter Vonberg, Philipp Solbach, et al.. (2015). Microbiological analysis of bile and its impact in critically ill patients with secondary sclerosing cholangitis. Journal of Infection. 70(5). 483–490. 27 indexed citations
7.
Lankisch, Tim O., Torsten Voigtländer, Michael P. Manns, et al.. (2014). MicroRNAs in the bile of patients with biliary strictures after liver transplantation. Liver Transplantation. 20(6). 673–678. 20 indexed citations
8.
Landi, Abdolamir, Tobias J. Weismüller, Tim O. Lankisch, et al.. (2013). Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis. Journal of Interferon & Cytokine Research. 34(3). 204–214. 47 indexed citations
9.
Lenzen, Henrike, Tobias J. Weismüller, Ahmed Negm, et al.. (2013). Antineutrophil cytoplasmic antibodies in bile are associated with disease activity in primary sclerosing cholangitis. Scandinavian Journal of Gastroenterology. 48(10). 1205–1212. 6 indexed citations
10.
Metzger, Jochen, Ahmed Negm, Ruben R. Plentz, et al.. (2012). Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders. Gut. 62(1). 122–130. 113 indexed citations
11.
Weismüller, Tobias J. & Tim O. Lankisch. (2011). Medical and endoscopic therapy of primary sclerosing cholangitis. Best Practice & Research Clinical Gastroenterology. 25(6). 741–752. 15 indexed citations
12.
Lankisch, Tim O., et al.. (2011). Biliary stent migration with colonic perforation: a very rare complication and the lesson that should be learned from it. Gastrointestinal Endoscopy. 74(4). 924–925. 10 indexed citations
13.
Lankisch, Tim O., Elmar Jaeckel, & Christian P. Strassburg. (2009). The Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy or Autoimmune Polyglandular Syndrome Type 1. Seminars in Liver Disease. 29(3). 307–314. 29 indexed citations
14.
Lankisch, Tim O., Georg M. N. Behrens, Ursula Ehmer, et al.. (2009). Gilbert’s syndrome and hyperbilirubinemia in protease inhibitor therapy – An extended haplotype of genetic variants increases risk in indinavir treatment. Journal of Hepatology. 50(5). 1010–1018. 30 indexed citations
15.
Lankisch, Tim O., Michael P. Manns, & Jochen Wedemeyer. (2008). Why Men Should Not Iron: Unperceived Swallowed Dental Root Instrument Causes Seven Years of Abdominal Pain. Clinical Gastroenterology and Hepatology. 6(9). A32–A32. 1 indexed citations
16.
Lankisch, Tim O., Thomas Erichsen, Ursula Ehmer, et al.. (2008). Aryl hydrocarbon receptor-mediated regulation of the human estrogen and bile acid UDP-glucuronosyltransferase 1A3 gene. Archives of Toxicology. 82(9). 573–582. 33 indexed citations
17.
Strassburg, Christian P., Tim O. Lankisch, Michael P. Manns, & Ursula Ehmer. (2008). Family 1 uridine-5′-diphosphate glucuronosyltransferases (UGT1A): from Gilbert’s syndrome to genetic organization and variability. Archives of Toxicology. 82(7). 415–433. 33 indexed citations
18.
Lankisch, Tim O., Michael Wehmeier, Georg M. N. Behrens, et al.. (2006). Gilbert's disease and atazanavir: From phenotype to UDP-glucuronosyltransferase haplotype. Hepatology. 44(5). 1324–1332. 104 indexed citations
19.
Lankisch, Tim O., Arndt Vogel, Anette Fiebeler, et al.. (2005). Identification and Characterization of a Functional TATA Box Polymorphism of the UDP Glucuronosyltransferase 1A7 Gene. Molecular Pharmacology. 67(5). 1732–1739. 56 indexed citations
20.
Lankisch, Tim O., Christian P. Strassburg, Dominique Debray, Michael P. Manns, & Emmanuel Jacquemin. (2005). Detection of Autoimmune Regulator Gene Mutations in Children with Type 2 Autoimmune Hepatitis and Extrahepatic Immune-mediated Diseases. The Journal of Pediatrics. 146(6). 839–842. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026